 |
 |
 |
 |
 |
 |
Specimen Source |
|
|
|
|
SAMPLE ID |
|
|
|
|
CEBPA Mutation |
PCR |
Not Detected |
|
|
 |
 |
 |
 |
| PRIMARY |
| 1 |
Whole Blood EDTA |
5 (2) mL
|
Room Temperature - 7 Day(s)/Refrigerated - 7 Day(s) |
|
| ALTERNATE |
|
The CEBPA gene, a myeloid transcription factor, is mutated in a subset of acute myeloid leukemia (AML), particularly those with chromosome analyses showing normal diploid karyotype, Cytogenetically Normal (CN). CN-AML that have CEBPA mutations show favorable outcome compared to other groups of CN-AML. Testing for CEBPA mutation, along with NPM1 (16158 test code) and FLT3 mutations (test code 90574) is recommended for all patients with CN-AML.
|
5 mL EDTA (lavender-top) tube whole blood
Do not freeze. FFPE is a validated specimen type, however, it is not
routinely performed.
Cell Pellet Instructions: This assay is also designed for the
remnant cell pellet from Cytogenetics. The cell pellet usually
fixed should be transported at room temperature or refrigerated
to the laboratory as soon as possible. Please provide a copy of
the Cytogenetics report.
Reject Criteria: Gross hemolysis
Transport Temperature: Ship room temperature
|
|
| Setup Schedule |
| Tuesday, Thursday, Saturday |
| Reported (Analytical Time) |
|
3 days
|
|
CPT Code
|
81218
The CPT codes provided are based on AMA guidelines and are for informational purposes only.
CPT coding is the sole responsibility of the billing party.
Please direct any questions regarding coding to the payer being billed.
|
|
